Skip to main content
Log in

Parathyroidectomy for Renal Hyperparathyroidism in Children and Adolescents

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Renal hyperparathyroidism (rHPT) almost inevitably develops in pediatric patients with end-stage chronic kidney disease (CKD) and may require parathyroidectomy (PTX) despite intensified conservative therapy. Long-term duration of uncontrolled rHPT may result in disabling osteodystrophy and vascular calcifications. Only a few reports on children undergoing PTX for rHPT are available and mainly consist of case reports with short follow-up periods. To study this entity, we analyzed the course of 23 pediatic patients who underwent PTX for rHPT.

Methods

Twenty-three patients with a mean age of 15 years and who underwent PTX for rHPT between 1986 and 2006 were evaluated. Surgical indications and techniques, specific postoperative management, and follow-up courses are described.

Results

Preoperative mean serum (s-) calcium was 2.7 ± 0.05 mmol/L (normal range = 2.2–2.7 mmol/L); s-phosphate was 1.8 ± 0.1 mmol/L (normal range = 0.8–1.6 mmol/L), and mean intact parathyroid hormone (PTH) level was 1240.1 ± 160.1 pg/ml (normal range = 11–65 pg/ml). Twenty-one patients underwent initial PTX and two patients underwent reoperative PTX. Total PTX with parathyroid autotransplantation (AT) was performed in 18 patients. In three patients less than four parathyroid glands were identified and no AT was performed consecutively. Postoperatively, no complications with respect to bleeding or vocal cord damage were recorded. The postoperative values of s-calcium, s-phosphate, and PTH decreased to or below normal range (s-calcium = 2.0 ± 0.1 mmol/L, s-phosphate = 1.2 ± 0.1 mmol/L, PTH = 50.1 ± 11.2 pg/ml). All 15 children below the age of 15 years required calcium intravenously. Follow-up was obtained in all patients 69.6 ± 11.4 months after PTX. Bone pain resolved in all previously symptomatic patients. S-calcium was 2.2 ± 0.2 mmol/L, s-phosphate was 1.4 ± 0.3 mmol/L, and PTH was 90.2 ± 21.5 pg/ml. No patient required repeated parathyroid autografting, and only one underwent an explantation of his AT six years after initial PTX.

Conclusion

Total PTX with AT in pediatric patients with rHPT is a safe and effective procedure. It should be considered if rHPT is refractory to conservative treatment, in view of the risk of potentially lethal vascular calcifications developing in the majority of adults with childhood onset of CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Frei U, Schober-Halstenberg HJ (2006) Summary of the Annual Report on Dialysis Treatment and Renal Transplantation in Germany for 2005/2006. QuaSi-Niere 14(5):1085–1090

    Google Scholar 

  2. Ardissino G, Dacco V, Testa S, et al. (2003) Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111(4 Pt 1):e382–e387

    Article  PubMed  Google Scholar 

  3. Zachariou Z, Buhr H, von Herbay A, et al. (1995) Preoperative diagnostics and surgical management of tertiary hyperparathyroidism after chronic renal failure in a child. Eur J Pediatr Surg 5(5):288–291

    Article  PubMed  CAS  Google Scholar 

  4. Sanchez CP (2003) Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment. Paediatr Drugs 5(11):763–776

    Article  PubMed  Google Scholar 

  5. Klaus G, Watson A, Edefonti A, et al. (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21(2):151–159

    Article  PubMed  CAS  Google Scholar 

  6. Berard E, Crosca G, Broyer M, et al. (1989) Parathyroidectomy in children with renal failure. Retrospective study of 17 cases. Arch Fr Pediatr 46(6):417–424

    PubMed  CAS  Google Scholar 

  7. National Kidney Foundation (2007) Counahan-Barratt method to calculate GFR in children and adolescents. Available at http://www.kidney.org/professionals/kdoqi/gfr_calculatorPed.cfm. Accessed 20 May 2007

  8. Nelson AW, Mackinnon B, Traynor J, et al. (2006) The relationship between serum creatinine and estimated glomerular filtration rate: implications for clinical practice. Scott Med J 51(4):5–9

    PubMed  CAS  Google Scholar 

  9. Kuizon BD, Goodman WG, Juppner H, et al. (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53(1):205–211

    Article  PubMed  CAS  Google Scholar 

  10. Schmitt CP, Ardissino G, Testa S, et al. (2003) Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18(5):440–444

    PubMed  Google Scholar 

  11. National Kidney Foundation (2005) Kidney Disease Outcomes Quality Intitiative (K/DOQI) clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46(Suppl 1):xxx-xxx

    Google Scholar 

  12. Storms LE, Chicella MF, Dice JE (2006) Sevelamer therapy for pediatric end-stage renal disease. Pharmacotherapy 26(3):410–413

    Article  PubMed  Google Scholar 

  13. Pieper AK, Haffner D, Hoppe B, et al. (2006) A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 47(4):625–635

    Article  PubMed  CAS  Google Scholar 

  14. Seeherunvong W, Nwobi O, Abitbol CL, et al. (2006) Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol 21(10):1434–1439

    Article  PubMed  Google Scholar 

  15. Chang W, Tu C, Chen TH, et al. (1999) Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 140(12):5883–5893

    Article  PubMed  CAS  Google Scholar 

  16. National Institutes of Health, Cinacalcet (Sensipar TM): a brief review. Available at http://clinicalcenter.nih.gov/phar/updates/pdf/pharmacyupdatemayjun04.pdf. Pharmacy Update May/June 2004

  17. Riley TN, DeRuiter J (2004) What are the actions of cinacalcet hydrochloride (Sensipar) in the treatment of secondary hyperparathyroidism? US Pharm 29(12):HS8–HS16

    Google Scholar 

  18. Amgen Inc. (2004) Prescribing information for Sensipar™ (Cinacalcet HCl) tablets

  19. Yang JY, Yao Y (2004) Analysis of 1268 patients with chronic renal failure in childhood: a report from 91 hospitals in China from 1990 to 2002. Zhonghua Er Ke Za Zhi 42(10):724–730

    PubMed  Google Scholar 

  20. Firor HV, Moore ES, Levitsky LL, et al. (1972) Parathyroidectomy in children with chronic renal failure. J Pediatr Surg 7(5):565–572

    Article  PubMed  CAS  Google Scholar 

  21. Fine RN (1973) Severe renal osteodystrophy (ROD) in small children: treatment with total parathyroidectomy (PTX). Pediatr Res 7(1):45–67

    Google Scholar 

  22. Talwalkar YB, Puri HC, Hawker CC, et al. (1979) Parathyroid autotransplantation in renal osteodystrophy. Am J Dis Child 133(9):901–905

    PubMed  CAS  Google Scholar 

  23. Moazam F, Orak JK, Fennell RS III, et al. (1984) Total parathyroidectomy and autotransplantation for tertiary hyperparathyroidism in children with chronic renal failure. J Pediatr Surg 19(4):389–393

    Article  PubMed  CAS  Google Scholar 

  24. Martinez L, Alonso A, Meseguer MC, et al. (1997) [Surgical treatment of tertiary hyperparathyroidism in childhood]. Cir Pediatr 10(1):13–17

    PubMed  CAS  Google Scholar 

  25. Ross AJ III (1991) Parathyroid surgery in children. Prog Pediatr Surg 26:48–59

    PubMed  Google Scholar 

  26. Jofre R, Lopez Gomez JM, Menarguez J, et al. (2003) Parathyroidectomy: whom and when? Kidney Int Suppl 85:S97–100

    Article  PubMed  Google Scholar 

  27. Zahiri K, Hachim K, Fatihi EM, et al. (2002) Calcium needs in hemodialyzed-parathyroidectomized patients. Ann Med Intern (Paris) 153(7):433–439

    CAS  Google Scholar 

  28. Davenport A, Stearns MP (2007) Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome. Nephrology (Carlton) 12(4):386–390

    Article  CAS  Google Scholar 

  29. Oh J, Wunsch R, Turzer M, et al. (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106(1):100–105

    Article  PubMed  Google Scholar 

  30. Salusky IB, Foley J, Nelson P, et al. (1991) Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 324(8):527–531

    Article  PubMed  CAS  Google Scholar 

  31. Civilibal M, Caliskan S, Oflaz H, et al. (2007) Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr Nephrol 22:1021-1029

    Article  PubMed  Google Scholar 

  32. Civilibal M, Caliskan S, Adaletli I, et al. (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21(10):1426–1433

    Article  PubMed  Google Scholar 

  33. Querfeld U (2004) The clinical significance of vascular calcification in young patients with end-stage renal disease. Pediatr Nephrol 19(5):478–484

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katja Schlosser.

Additional information

K. Schlosser and C. P. Schmitt contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schlosser, K., Schmitt, C.P., Bartholomaeus, J.E. et al. Parathyroidectomy for Renal Hyperparathyroidism in Children and Adolescents. World J Surg 32, 801–806 (2008). https://doi.org/10.1007/s00268-007-9318-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-007-9318-6

Keywords

Navigation